Low doses of etanercept can be effective in ankylosing spondylitis patients who achieve remission of the disease

This study aims to explore the effectiveness of low dose of etanercept (ETN) in patients with ankylosing spondylitis (AS) who achieve a good control of their disease in daily clinical practice. This is a case series of AS patients treated with ETN. According to the judgment of the treating rheumatol...

Full description

Saved in:
Bibliographic Details
Published in:Clinical rheumatology 2011-07, Vol.30 (7), p.993-996
Main Authors: Navarro-Compán, Victoria, Moreira, Virginia, Ariza-Ariza, Rafael, Hernández-Cruz, Blanca, Vargas-Lebrón, Carmen, Navarro-Sarabia, Federico
Format: Article
Language:English
Subjects:
Adult
Antirheumatic Agents - therapeutic use
Brief Report
Dose-Response Relationship, Drug
Etanercept
Female
Health Status
Humans
Immunoglobulin G - therapeutic use
Male
Medicine
Medicine & Public Health
Middle Aged
Receptors, Tumor Necrosis Factor - therapeutic use
Remission Induction
Rheumatology
Severity of Illness Index
Spondylitis, Ankylosing - drug therapy
Spondylitis, Ankylosing - physiopathology
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This study aims to explore the effectiveness of low dose of etanercept (ETN) in patients with ankylosing spondylitis (AS) who achieve a good control of their disease in daily clinical practice. This is a case series of AS patients treated with ETN. According to the judgment of the treating rheumatologist and patient's preferences, a dose reduction was done in those patients who achieved a good control of their disease defined by Bath ankylosing spondylitis disease activity index (BASDAI)
ISSN:0770-3198
1434-9949
DOI:10.1007/s10067-011-1722-5